ISSN 2097-6046(网络)
ISSN 2096-7446(印刷)
CN 10-1655/R
主管:中国科学技术协会
主办:中华护理学会
重症护理研究

肝糖原累积病合并脓毒症伴冷凝集现象患者的护理

  • 潘银芝 ,
  • 杨旻斐
展开
  • 310052 杭州市 浙江大学医学院附属第二医院护理部
潘银芝:女,本科(硕士在读),主管护师,E-mail:316888279@qq.com

收稿日期: 2024-03-19

  网络出版日期: 2025-01-22

Nursing care of a patient with glycogen storage disease complicated with sepsis and cold agglutination phenomenon

  • PAN Yinzhi ,
  • YANG Minfei
Expand

Received date: 2024-03-19

  Online published: 2025-01-22

摘要

总结1例肝糖原累积病合并脓毒症伴冷凝集现象患者的护理体会。肝糖原累积病是罕见的代谢障碍性疾病,发热、感染等因素易诱发急性代谢危象,且患者伴冷凝集现象,其治疗及护理均较为复杂,护理要点包括血糖及营养管理、纠正酸中毒、控制感染、基于循证的目标体温管理、确保输血安全。经过8 d积极治疗和精心护理,患者病情好转并顺利出院,出院后随访6个月,按计划复诊,状态良好。

本文引用格式

潘银芝 , 杨旻斐 . 肝糖原累积病合并脓毒症伴冷凝集现象患者的护理[J]. 中华急危重症护理杂志, 2025 , 6(2) : 201 -203 . DOI: 10.3761/j.issn.2096-7446.2025.02.012

Abstract

To summarize the nursing experience of a patient with glycogen storage disease complicated with sepsis and cold agglutination phenomenon. Glycogen storage disease is a rare metabolic disorder,factors such as fever and infection can easily induce acute metabolic crisis,and the patient was accompanied by cold agglutination,its treatment and nursing were complicated. The key points of nursing care included blood sugar and nutrition management,acidosis correction,infection control,evidence-based target body temperature management,ensuring safe blood transfusion. After 8 days of active treatment and careful nursing care,the patient’s condition improved and she was discharged. After 6 months of follow-up,she returned to the hospital as scheduled,the recovery was good.

参考文献

[1] Kishnani PS, Austin SL, Abdenur JE, et al. Diagnosis and ma-nagement of glycogen storage disease type I:a practice gui-deline of the American College of Medical Genetics and Genomics[J]. Genet Med, 2014, 16(11):e1.
[2] Parikh NS, Ahlawat R. Glycogen storage disease type I[M]. Clearwater: StatPearls Publishing, 2022.
[3] Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis cam-paign:international guidelines for management of sepsis and septic shock 2021[J]. Intensive Care Med, 2021, 47(11):1181-1247.
[4] Derks TGJ, Rodriguez-Buritica DF, Ahmad A, et al. Glycogen storage disease type ia:current management options,burden and unmet needs[J]. Nutrients, 2021, 13(11):3828.
[5] Berentsen S, R?th A, Randen U, et al. Cold agglutinin disease:current challenges and future prospects[J]. J Blood Med, 2019, 10:93-103.
[6] Berentsen S. New insights in the pathogenesis and therapy of cold agglutinin-mediated autoimmune hemolytic anemia[J]. Front Immunol, 2020, 11:590.
[7] Pitoulias AG, Bakr NA, Kazemtash M, et al. Von gierke disease (glycogen storage disease type I) and life-threatening abdomi-nal aortic aneurysm:a case report of an extremely rare condi-tion[J]. Vasc Specialist Int, 2023, 39:14.
[8] 陈永兴, 梁黎黎, 王晓建, 等. 糖原累积病Ⅰa型的诊断治疗和预防专家共识[J]. 中国实用儿科杂志, 2022, 37(9):641-649.
  Chen YX, Liang LL, Wang XJ, et al. Expert consensus on the diagnosis,treatment and prevention of glycogen storage disease type Ⅰa[J]. Chin J Pract Pediatr, 2022, 37(9):641-649.
[9] Kruse O, Grunnet N, Barfod C. Blood lactate as a predictor for in-hospital mortality in patients admitted acutely to hospi-tal:a systematic review[J]. Scand J Trauma Resusc Emerg Med, 2011, 19:74.
[10] Berentsen S. Complement activation and inhibition in autoim-mune hemolytic anemia:focus on cold agglutinin disease[J]. Semin Hematol, 2018, 55(3):141-149.
[11] 李绮萍. 环境温度控制对冷凝集患者的输血影响[J]. 中国医药科学, 2017, 7(11):155-157,186.
  Li QP. Effect of environmental temperature controlling on blood transfusion of patients with cold agglutination[J]. China Med Pharm, 2017, 7(11):155-157,186.
文章导航

/